n Ontario-based company is now compensating donors for plasma, giving rise to a divide in the medical community about the safety and ethics of paying for blood.
Canadian Plasma Resources is waiting on license approval from Health Canada, but is already paying plasma donors in a pilot phase that's been approved by Institutional Review Board Services, according to CEO Barzin Bahardoust. The company has paid about 100 donors, so it can do quality testing and train staff at a site in downtown Toronto. Those who oppose paying donors often cite the 1997 report from the Commission on the Blood System in Canada, which recommended all blood and blood product donation be publicly administered and voluntarily donated after 1000 individuals contracted HIV and 33 000 contracted hepatitis C from blood products given by improperly screened donors.
But Canadian Blood Services and Health Canada say plasma from compensated donors, which is used for pharmaceutical therapies made from plasma protein not for direct transfusion, is safe. It's against Canadian Blood Services' policy to pay for blood or blood products, but it would be impossible for Canada to meet its growing plasma need by relying solely on voluntary donors. Only 30% of the plasma-derived immunoglobulin is now supplied through the voluntary donor system; the rest is purchased from US companies that pay donors, says Sher.
Bahardoust says his company aims to discourage "people who are unsuitable" by paying not in cash but in their choice of a $25 charitable donation to Toronto's Hospital for Sick Children or a $25 Visa gift card that can't be converted to cash. Tests, like a physical exam, vitals testing and serum protein analysis are all done "for the safety of the donor."
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Canadian Plasma Resources is not the first company to pay donors.
Cangene, a Winnipeg-based pharmaceutical company, has been paying plasma donors for three decades. It was launched to collect Rh-negative plasma to treat pregnant women, but also collects plasma for pharmaceutical purposes.
Dr. Ryan Mieli, a Saskatoon-based family doctor and vice-chair of Canadian Doctors for Medicare, says that given the testing methods, he's not worried about the risks to recipients of paid-plasma derived pharmaceuticals, but he is concerned about risks to donors.
Speaking as an individual, not for his organization, Mieli says that given the locations of the clinics and the amount paid, Canadian Plasma
Resources is "really targeting people who are low-income. They're profiting off of poverty…. I think that raises some significant ethical issues."
A review article in the Journal of Clinical Apheresis found that while adverse reactions to the donation of blood components were less frequent than with whole blood donation, the risk of reactions leading to hospitalization were greater in the former, and that the long-term effects of frequent blood component donation requires additional study. (Because the donor's red blood cells are returned after the plasma is separated out, donors can give plasma every week, while whole blood donors can give every eight weeks.)
Mieli says that "If we absolutely do have to pay people to get plasma, we should do it through Canadian Blood Services." DOI:10.1503/cmaj.109-4855 
